iTRAQ based proteomic analysis of PM_2.5 induced lung damage

Area of Science:

• Environmental Health
• Toxicology
• Biochemistry

Background:

• Haze pollution, particularly from fine particulate matter (PM2.5), poses global environmental and health risks.
• PM2.5 exposure is linked to adverse pulmonary diseases like asthma and lung cancer.
• Current clinical diagnosis and treatment of PM2.5-induced lung damage are challenged by the absence of specific biomarkers and identified pathways.

Purpose of the Study:

• To investigate the molecular mechanisms of PM2.5-induced lung damage.
• To identify novel protein biomarkers and signaling pathways associated with PM2.5 toxicity in the lungs.
• To provide fundamental research clues for early diagnosis and therapeutic strategies.

Main Methods:

• Establishment of a rat model via nonsurgical intratracheal instillation of PM2.5.
• Application of iTRAQ-based proteomics and bioinformatics analysis to identify differentially expressed proteins (DEPs).
• Verification of DEPs using Western-blotting in an alveolar epithelial cell type II (AEC-II) model.

Main Results:

• Identification of 163 differentially expressed proteins (DEPs) in response to PM2.5 exposure.
• Screening of six DEPs (HMOX1, MP2K5, XRCC1, E9PTZ7, KNT2, A1AG) as putative biomarkers with significant expression changes (>140% increment).
• Pathway analysis implicated calcium signaling, MAPK, and PI3K/AKT signaling in PM2.5-induced lung damage.

Conclusions:

• The identified DEPs serve as potential biomarkers for PM2.5-induced lung toxicity.
• Calcium signaling, MAPK, and PI3K/AKT pathways are likely involved in the pathogenesis of PM2.5 lung damage.
• This research provides a foundation for developing diagnostic tools and understanding PM2.5-related lung diseases.